Beximco Pharmaceuticals Limited
BXP.L · LSE
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | £5,867 | £4,524 | £5,123 | £5,128 |
| Dep. & Amort. | £1,994 | £2,061 | £370 | £1,114 |
| Deferred Tax | £0 | £0 | £0 | £0 |
| Stock-Based Comp. | £0 | £0 | £0 | £0 |
| Change in WC | £433 | -£734 | -£1,909 | -£653 |
| Other Non-Cash | £71 | £234 | £1,630 | £434 |
| Operating Cash Flow | £8,364 | £6,085 | £5,493 | £6,023 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -£1,994 | -£2,411 | -£2,939 | -£2,558 |
| Net Acquisitions | £0 | £0 | -£4,767 | £0 |
| Inv. Purchases | £0 | £0 | £0 | £0 |
| Inv. Sales/Matur. | £0 | £0 | £0 | £0 |
| Other Inv. Act. | -£413 | -£206 | £26 | £34 |
| Investing Cash Flow | -£2,406 | -£2,617 | -£7,680 | -£2,525 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -£4,674 | -£1,993 | £4,238 | -£505 |
| Stock Issued | £0 | £0 | £0 | £0 |
| Stock Repurch. | £0 | £0 | £0 | £0 |
| Dividends Paid | -£1,586 | -£1,568 | -£1,623 | -£578 |
| Other Fin. Act. | £0 | £0 | £0 | -£2,375 |
| Financing Cash Flow | -£6,260 | -£3,561 | £2,615 | -£3,458 |
| Forex Effect | £20 | £60 | £45 | £0 |
| Net Chg. in Cash | -£282 | -£33 | £195 | £40 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £1,136 | £1,169 | £974 | £635 |
| End Cash | £854 | £1,136 | £1,169 | £675 |
| Free Cash Flow | £6,130 | £3,375 | £2,554 | £3,465 |